Study Notes on Herpes and Hepatitis

Understanding Herpes and Its Transmission

  • Nature of Herpes

    • Herpes is classified as a latent virus.

    • It integrates into the host's DNA, making it a permanent part of the genome.

    • Once contracted, the virus remains in the body, and there is currently no definitive cure, but research is ongoing with technologies like CRISPR aimed at targeting the virus.

  • Transmission Mechanism

    • Transmits primarily through skin contact rather than through bodily fluids.

    • Condoms offer limited protection against herpes, with efficacy rates as low as 25% to 50%.

  • Types of Herpes

    • The most common types relevant to human infection are HSV-1 and HSV-2.

    • HSV-2 predominantly causes genital herpes, while HSV-1 is typically associated with oral herpes.

    • However, it's increasingly noted that HSV-1 can also cause genital herpes, especially through oral sex.

  • Asymptomatic Shedding

    • Individuals can transmit the virus even when they exhibit no symptoms, a process known as asymptomatic shedding.

    • Lack of visible lesions does not imply the absence of the virus.

  • Female vs. Male Risks

    • Statistically, about 22% of females in the U.S. and 12% of males are infected with genital herpes.

    • Females are at a higher risk due to anatomical surface area exposure, not behavioral factors.

  • Neonatal Herpes

    • If a female carrier has herpes during childbirth, the virus can be transmitted to the neonate as it passes through the birth canal.

    • prenatal care includes antiviral treatments to minimize outbreak risk close to the delivery date, and in cases of active lesions, a C-section is often recommended.

    • Mortality is notably high (around 80%) for neonates if herpes infects the central nervous system, emphasizing the severe implications.

Hepatitis Overview

  • Types of Hepatitis

    • Hepatitis is categorized primarily into A, B, C, D, and E based on transmission routes and vaccine availability:

      • Hepatitis A - Vaccine available; transmission is mainly fecal-oral.

      • Hepatitis B - Vaccine available; sexual transmission and through contaminated needles.

      • Hepatitis C - No vaccine; primarily bloodborne transmission.

      • Hepatitis D - Requires pre-existing Hepatitis B for infection (co-infection or superinfection); no separate vaccine.

      • Hepatitis E - Vaccine available outside the U.S.; transmission is mostly fecal-oral.

  • Transmission and Risks of Hepatitis B

    • Transmission Modes: Mainly through sexual contact, contaminated needles, and mother-child during birth.

    • Incubation Period: Symptoms develop over several weeks; acute phase characterized by symptoms like jaundice, fatigue, and gastrointestinal issues.

    • Chronic Phase: Possibility exists to transition from acute to chronic hepatitis, particularly in infants and those infected at younger ages.

    • Clear rates differ by age: infants born with Hepatitis B have up to a 90% chance of developing chronic infection.

  • Symptoms

    • Acute phase indicators include jaundice (yellowing of skin/eyes), fatigue, fever, and gastrointestinal distress.

    • Chronic infection may lead to liver damage and increased risk of liver cancer.

Hepatitis D Specifics

  • Pathogenesis

    • Hepatitis D requires presence of Hepatitis B to replicate.

    • Can present as co-infection (simultaneous infection) or superinfection (having Hepatitis B first and then contracting Hepatitis D).

    • Outcomes of superinfection are generally worse, leading to more chronic forms and severe complications than co-infections.

  • Preventative Measures

    • Vaccination against Hepatitis B prevents Hepatitis D, thereby eliminating its chance of infection.

    • Understanding of both virus interactions is crucial for prevention strategies.

Hepatitis C Overview

  • Transmission

    • Spread mainly through blood, sexual contact, and sharing contaminated needles.

    • No direct vaccine exists, but antiviral treatments can help manage the virus post-exposure.

    • Only 20-30% will exhibit acute symptoms; the rest remain asymptomatic, which complicates awareness and treatment seeking.

    • If symptoms do manifest, there’s a 75-85% likelihood of developing a chronic infection from acute cases.

  • Chronic Hepatitis C

    • Chronicity leads to increased risk for liver cirrhosis, liver cancer, and liver failure.

    • Treatment options are evolving, and antiviral therapies have shown positive success rates in managing the condition.

  • Circumstances of Infection

    • Risks associated with drug use, especially during needle sharing, and the need for preventive education about safe practices.

    • Professionals working in healthcare, particularly in ER services, face higher risk scenarios requiring vigilant preventive strategies.